InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Explore the full record of transactions filed by HALE DAVID F, Director. Officer active across 3 companies, notably Dermata Therapeutics, Inc.. In total, 7 reports have been published. Total volume traded: €32k. The latest transaction was filed on 7 April 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations7 total
015,466 shares0
Common Stock
SEC:0000905718-22-000562:0·
€1,299363 shares@ €3.5787100.0% of flow
Common Stock
SEC:0001209191-21-069092·
€1,299363 shares@ €3.578750.0% of flow
Common Stock
SEC:0001209191-21-069092:0·
44,777 shares
Common Stock
SEC:0000905718-21-001110·
44,777 shares
Common Stock
SEC:0000905718-21-001110:0·
€14,6993,669 shares@ €4.0061100.0% of flow
Common Stock
SEC:0001209191-21-045049·
€14,6993,669 shares@ €4.006150.0% of flow
Common Stock
SEC:0001209191-21-045049:0·
7 of 7 declarations
About HALE DAVID F
HALE DAVID F is a Director at Oncternal Therapeutics, Inc., Dermata Therapeutics, Inc., and BIOCEPT INC. In these roles, he participates in corporate governance and strategic decision-making. His expertise in the biopharmaceutical sector allows him to make significant contributions to board discussions, ensuring innovation and performance for the companies.
